Nuclear hormone receptors, microRNAs form developmental switch

Apr 02, 2009

A particular nuclear hormone receptor called DAF-12 and molecules called microRNAs in the let-7 family form a molecular switch that encourages cells in the larvae of a model worm to shift to a more developed state, said a consortium led by researchers from Baylor College of Medicine in a report that appears online today in the journal Science.

As organisms go through the stages of life, hormones coordinate the changes. Nuclear receptors respond to hormones to coordinate stage transitions, but how they do so is not well understood.

"We knew that nuclear hormone receptors were involved in stage 2 to stage 3 transitions in Caenorhabditis elegans," said Dr. Adam Antebi, associate professor in the Huffington Center on Aging at BCM and the report's senior author. "Another class of called microRNAs is also involved in that transition. We hypothesized that maybe if they are involved in the same process, one turns on the other."

That turns out to be the case in C. elegans and may be true in more advanced organisms as well, he said.

Scientists use the tiny worm called Caenorhabditis elegans to study such processes because it has a simple anatomy and life cycle. C. elegans develops from embryo through four larval stages into adulthood.

Each "stage" has specific programs of cell division, migration, differentiation and death that are crucial to the organism's final development. Particular master regulators in the worm determine each stage transition and are responsible for organizing developmental time.

"Expression of the let-7 family of microRNAs is dependent on the nuclear receptor and its hormone," Antebi said. "We can show in the worm and in cell culture that DAF-12 and its steroid hormone are directly activating these microRNAs."

But how does this cause stage transitions? The tiny molecules called microRNAs work as switches to turn off other genes. In this case, the nuclear hormone receptor DAF-12 and its ligand turn on the microRNAs, which then turn off the earlier developmental "programming" of the cell (stage 2), allowing the later programming (stage 3) to take over.

Specifically, the microRNAs dial-back the activity of a protein called "hunchback," which specifies that the cells are in stage 2. That enables stage 3 to start and development to continue.

"We think this could also give insight into cancers," Antebi said, "particularly those that are hormone-dependent, such as breast or prostate cancer. When worm skin cells go from stage 2 to stage 3 they reduce their cell proliferation. When they fail this transition, skin cells overproliferate (grow uncontrollably)."

It is known that both nuclear receptors and microRNAs play a role in human cancers. These studies could help bridge understanding of the effects of the two.

Antebi also thinks that this system links development to the environment. DAF-12 plays a role in a long-lived quiescent stage called the dauer diapause, which the worms enter in times of starvation and overcrowding.

"In good times, the DAF-12 steroid ligand is made, the microRNAs are turned on, and the worm goes through all stages of development to adult," said Antebi. (A ligand is a molecule that binds to the receptor to form a biologically active complex.)

"In bad times, the ligand is not made and the nuclear receptor (DAF-12) causes the animals to go into the long lived dauer stage, shutting down the microRNAs and the developmental clock," he said.

In this way, environmental signals actually affect the worm's rate of development, and perhaps even its aging, said Antebi.

Source: Baylor College of Medicine (news : web)

Explore further: Novel marker discovered for stem cells derived from human umbilical cord blood

add to favorites email to friend print save as pdf

Related Stories

Mechanism of microRNAs deciphered

May 16, 2007

Over 30% of our genes are under the control of small molecules called microRNAs. They prevent specific genes from being turned into protein and regulate many crucial processes like cell division and development, but how they ...

Recommended for you

New pain relief targets discovered

1 hour ago

Scientists have identified new pain relief targets that could be used to provide relief from chemotherapy-induced pain. BBSRC-funded researchers at King's College London made the discovery when researching ...

Building 'smart' cell-based therapies

1 hour ago

A Northwestern University synthetic biology team has created a new technology for modifying human cells to create programmable therapeutics that could travel the body and selectively target cancer and other ...

Proper stem cell function requires hydrogen sulfide

4 hours ago

Stem cells in bone marrow need to produce hydrogen sulfide in order to properly multiply and form bone tissue, according to a new study from the Center for Craniofacial Molecular Biology at the Herman Ostrow School of Dentistry ...

User comments : 0

More news stories

New pain relief targets discovered

Scientists have identified new pain relief targets that could be used to provide relief from chemotherapy-induced pain. BBSRC-funded researchers at King's College London made the discovery when researching ...

Study recalculates costs of combination vaccines

One of the most popular vaccine brands for children may not be the most cost-effective choice. And doctors may be overlooking some cost factors when choosing vaccines, driving the market toward what is actually a more expensive ...

Hackathon team's GoogolPlex gives Siri extra powers

(Phys.org) —Four freshmen at the University of Pennsylvania have taken Apple's personal assistant Siri to behave as a graduate-level executive assistant which, when asked, is capable of adjusting the temperature ...

Deadly human pathogen Cryptococcus fully sequenced

Within each strand of DNA lies the blueprint for building an organism, along with the keys to its evolution and survival. These genetic instructions can give valuable insight into why pathogens like Cryptococcus ne ...

Researchers discover target for treating dengue fever

Two recent papers by a University of Colorado School of Medicine researcher and colleagues may help scientists develop treatments or vaccines for Dengue fever, West Nile virus, Yellow fever, Japanese encephalitis and other ...